Reneo Pharmaceuticals, Inc. (RPHM)
Stock Price: $9.12 USD
0.22 (2.47%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
Income Statement (Annual)
Numbers in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 | |
|---|---|---|---|
| Revenue | - | - | |
| Selling, General & Admin | 3.61 | 2.38 | |
| Research & Development | 15.94 | 13.10 | |
| Operating Expenses | 19.55 | 15.47 | |
| Operating Income | -19.55 | -15.47 | |
| Other Expense / Income | -0.09 | -3.04 | |
| Pretax Income | -19.47 | -12.44 | |
| Net Income | -19.47 | -12.44 | |
| Shares Outstanding (Basic) | 2.03 | 1.95 | |
| Shares Outstanding (Diluted) | 2.03 | 1.95 | |
| Shares Change | 4.11% | - | |
| EPS (Basic) | -9.60 | -6.38 | |
| EPS (Diluted) | -9.60 | -6.38 | |
| Free Cash Flow Per Share | -9.15 | -6.43 | |
| EBITDA | -19.43 | -12.40 | |
| EBIT | -19.47 | -12.44 |